Moderna Execs Hyped Ineffective RSV Vax, Suit Says
By Julie Manganis · September 24, 2024, 6:15 PM EDT
Officers and directors of Moderna misled investors about the efficacy of its RSV vaccine, causing share prices to dive when it was revealed in June to have only about a 50%...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login